2,598 results on '"Amin, H"'
Search Results
152. Comparison of coercivity and squareness in hot-deformed and sintered magnets produced from a Nd-Fe-B-Cu-Ga alloy
- Author
-
Xu, X.D., Sepehri-Amin, H., Sasaki, T.T., Soderžnik, M., Tang, X., Ohkubo, T., and Hono, K.
- Published
- 2019
- Full Text
- View/download PDF
153. Magnetization reversal process of anisotropic hot-deformed magnets observed by magneto-optical Kerr effect microscopy
- Author
-
Soderžnik, M., Li, J., Liu, Lihua, Sepehri-Amin, H., Ohkubo, T., Sakuma, N., Shoji, T., Kato, A., Schrefl, T., and Hono, K.
- Published
- 2019
- Full Text
- View/download PDF
154. Critical care usage after major gastrointestinal and liver surgery: a prospective, multicentre observational study
- Author
-
McLean, K.A., Glasbey, J.C., Borakati, A., Brooks, T.M., Chang, H.M., Choi, S.M., Goodson, R., Nielsen, M., Pronin, S., Salloum, N.L., Sewart, E., Vanniasegaram, D., Drake, T.M., Gillies, M.A., Harrison, E.M., Chapman, S.J., Khatri, C., Kong, C.Y., Claireaux, H.A., Bath, M.F., Mohan, M., McNamee, L., Kelly, M., Mitchell, H., Fitzgerald, J.E., Bhangu, A., Nepogodiev, D., Antoniou, I., Dean, R., Davies, N., Trecarten, S., Henderson, I., Holmes, C., Wylie, J., Shuttleworth, R.H., Jindal, A., Hughes, F., Gouda, P., Fleck, R., Hanrahan, M., Karunakaran, P., Chen, J.H., Sykes, M.C., Sethi, R.K., Suresh, S., Patel, P., Patel, M., Varma, R.K., Mushtaq, J., Gundogan, B., Bolton, W., Khan, T., Burke, J., Morley, R., Favero, N., Adams, R., Thirumal, V., Kennedy, E.D., Ong, K.K., Tan, Y.H., Gabriel, J., Bakhsh, A., Low, J.Y.L., Yener, A., Paraoan, V., Preece, R., Tilston, T.W., Cumber, E., Dean, S., Ross, T., McCance, E., Amin, H., Satterthwaite, L., Clement, K.D., Gratton, R., Mills, E.D., Chiu, S.M., Hung, G., Rafiq, N.M., Hayes, J.D.B., Robertson, K.L., Dynes, K., Huang, H.C., Assadullah, S., Duncumb, J.W., Moon, R.D.C., Poo, S.X., Mehta, J.K., Joshi, K.R., Callan, R., Norris, J.M., Chilvers, N.J., Keevil, H., Jull, P., Mallick, S., Elf, D., Carr, L., Player, C., Barton, E.C., Martin, A.L., Ratu, S.G., Roberts, E.J., Phan, P.N., Dyal, A.R., Rogers, J.E., Henson, A.D., Reid, N.B., Burke, D., Culleton, G., Lynne, S., Mansoor, S., Brennan, C., Blessed, R., Holloway, C., Hill, A., Goldsmith, T., Mackin, S., Kim, S., Woin, E., Brent, G., Coffin, J., Ziff, O., Momoh, Z., Debenham, R., Ahmed, M., Yong, C.S., Wan, J.C., Copley, H.C., Raut, P., Chaudhry, F.I., Nixon, G., Dorman, C., Tan, R., Kanabar, S., Canning, N., Dolaghan, M., Bell, N., McMenamin, M., Chhabra, A., Duke, K., Turner, L., Patel, T., Chew, L.S., Mirza, M., Lunawat, S., Oremule, B., Ward, N., Khan, M., Tan, E.T., Maclennan, D., McGregor, R.J., Chisholm, E.G., Griffin, E.J., Bell, L., Hughes, B.A., Davies, J., Haq, H., Ahmed, H., Ungcharoen, N., Whacha, C., Thethi, R., Markham, R.M., Lee, A.H.Y., Batt, E., Bullock, N.P., Francescon, C.T., Davies, J.E., Shafiq, N.M., Zhao, J., Vivekanantham, S., Barai, I., Allen, J.L.Y., Marshall, D.C., McIntyre, C.J., Wilson, H.C.P., Ashton, A.J., Lek, C., Behar, N., Davis-Hall, M., Seneviratne, N., Esteve, L., Sirakaya, M., Ali, S., Pope, S., Ahn, J.S., Craig-McQuaide, A., Gatfield, W.A., Leong, S., Demetri, A.M., Kerr, A.L., Rees, C., Loveday, J., Liu, S., Wijesekera, M., Maru, D., Attalla, M., Smith, N., Brown, D., Sritharan, P., Shah, A., Charavanamuttu, V., Heppenstall-Harris, G., Ng, K., Raghvani, T., Rajan, N., Hulley, K., Moody, N., Williams, M., Cotton, A., Sharifpour, M., Lwin, K.N., Bright, M., Chitnis, A.R., Abdelhadi, M., Semana, A.D., Morgan, F., Reid, R., Dickson, J., Anderson, L., McMullan, R., Ahern, N., Asmadi, A., Anderson, L.B., Boon Xuan, J. Lua, Crozier, L., McAleer, S., Lees, D.M., Adebayo, A.A., Das, M., Amphlett, A.H., Al-Robeye, A., Valli, A., Khangura, J., Winarski, A., Ali, A., Woodward, H., Gouldthrope, C., Turner, M., Sasapu, K., Tonkins, M., Wild, J.R.L., Robinson, M., Hardie, J., Heminway, R., Narramore, R., Ramjeeawon, N., Hibberd, A., Winslow, F., Ho, W., Chong, B.F., Lim, K., Ho, S., Crewdson, J.A., Singagireson, S., Kalra, N., Koumpa, F., Jhala, H., Soon, W.C., Karia, M., Rasiah, M.G., Xylas, D., Gilbert, H., Sundar-Singh, M., Wills, J., Akhtar, S., Patel, S., Hu, L., Brathwaite-Shirley, C., Nayee, H., Amin, O., Rangan, T., Turner, E.J.H., McCrann, C., Shepherd, R., Patel, N., Prest-Smith, J., Auyoung, E., Murtaza, A., Coates, A., Prys-Jones, O., King, M., Gaffney, S., Dewdney, C.J., Nehikhare, I., Lavery, J., Bassett, J., Davies, K., Ahmad, K., Collins, A., Acres, M., Egerton, C., Cheng, K., Chen, X., Chan, N., Sheldon, A., Khan, S., Empey, J., Ingram, E., Malik, A., Johnstone, M., Goodier, R., Shah, J.P., Giles, J.E., Sanders, J.A., McLure, S.W., Pal, S., Rangedara, A., Baker, A.N., Asbjoernsen, C.A., Girling, C., Gray, L., Gauntlett, L., Joyner, C., Qureshi, S., Mogan, Y.P., Ng, J.C.K., Kumar, A.N., Park, J.H., Tan, D., Choo, K.P., Raman, K.P., Buakuma, P., Xiao, C., Govinden, S., Thompson, O.D., Charalambos, M.A., Brown, E., Karsan, R.B., Dogra, T., Bullman, L.M., Dawson, P.M., Frank, A.L., Abid, H., Tung, L., Qureshi, U., Tahmina, A., Matthews, B.W., Harris, R.T., O'Connor, A., Mazan, K., Iqbal, S., Stanger, S.A., Thompson, J.D., Sullivan, J.A.L., Uppal, E., MacAskill, A., Bamgbose, F.A., Neophytou, C., Carroll, A.F., Rookes, C.W., Datta, U., Dhutia, A.J., Rashid, S., Ahmed, N., Lo, T., Bhanderi, S., Blore, C.D., Ahmed, S., Shaheen, H., Abburu, S., Majid, S., Abbas, Z., Talukdar, S.S., Burney, L.J., Patel, J.B., Al-Obaedi, O., Roberts, A.W., Mahboob, S., Singh, B., Sheth, S., Karia, P., Prabhudesai, A., Kow, K., Koysombat, K., Wang, S., Morrison, P., Maheswaran, Y., Keane, P., Copley, P.C., Brewster, O., Xu, G.X., Harries, P., Wall, C., Al-Mousawi, A., Bonsu, S., Cunha, P., Ward, T., Paul, J., Nadanakumaran, K., Tayeh, S., Holyoak, H., Remedios, J., Theodoropoulou, K., Luhishi, A., Jacob, L., Long, F., Atayi, A., Sarwar, S., Parker, O., Harvey, J., Ross, H., Rampal, R., Thomas, G., Vanmali, P., McGowan, C., Stein, J., Robertson, V., Carthew, L., Teng, V., Fong, J., Street, A.N., Thakker, C.E., O'Reilly, D., Bravo, M., Pizzolato, A., Khokhar, H.A., Ryan, M., Cheskes, L., Carr, R., Salih, A.E., Bassiony, S., Yuen, R., Chrastek, D., Rosen O'Sullivan, H., Amajuoyi, A., Wang, A., Sitta, O., Wye, J., Qamar, M.A., Major, C., Kaushal, A., Morgan, C., Petrarca, M., Allot, R., Verma, K., Dutt, S., Chilima, C.P., Peroos, S., Kosasih, S.R., Chin, H., Ashken, L., Pearse, R.J., O'Loughlin, R.A., Menon, A., Singh, K., Norton, J., Sagar, R., Jathanna, N., Rothwell, L., Watson, N., Harding, F., Dube, P., Khalid, H., Punjabi, N., Sagmeister, M., Gill, P., Shahid, S., Hudson-Phillips, S., George, D., Ashwood, J., Lewis, T., Dhar, M., Sangal, P., Rhema, I.A., Kotecha, D., Afzal, Z., Syeed, J.A., Prakash, E., Jalota, P., Herron, J., Kimani, L., Delport, A., Shukla, A., Agarwal, V., Parthiban, S., Thakur, H., Cymes, W., Rinkoff, S., Turnbull, J.A., Hayat, M., Darr, S., Khan, U., Lim, J., Higgins, A., Lakshmipathy, G., Forte, B., Canning, E., Jaitley, A., Lamont, J., Toner, E., Ghaffar, A., McDowell, M., Salmon, D., O'Carroll, O., Khan, A., Kelly, M.E., Clesham, K., Palmer, C., Lyons, R., Bell, A., Chin, R., Waldron, R.M., Trimble, A., Cox, S.E., Ashfaq, U., Campbell, J., Holliday, R.B.S., McCabe, G., Morris, F., Priestland, R., Vernon, O.K., Ledsam, A., Vaughan, R., Lim, D., Bakewell, Z.R., Hughes, R.K., Koshy, R.M., Jackson, H.R., Narayan, P., Cardwell, A.E., Jubainville, C.L., Arif, T., Elliott, L.E., Gupta, V., Bhaskaran, G., Odeleye, A., Ahmed, F., Shah, R., Pickard, J., Suleman, Y.N., North, A.S., McClymont, L.F., Hussain, N., Ibrahim, I., Ng, G.S., Wong, V., Lim, A.E., Harris, L.N., Tharmachandirar, T., Mittapalli, D., Patel, V., Lakhani, M., Bazeer, H.Z., Narwani, V., Sandhu, K.K., Wingfield, L.R., Gentry, S., Adjei, H., Bhatti, M., Braganza, L., Barnes, J., Mistry, S., Chillarge, G., Stokes, S., Cleere, J., Wadanamby, S., Bucko, A.M., Meek, J., Boxall, N., Heywood, E.G., Wiltshire, J.J., Toh, C., Ward, A.E., Shurovi, B.N., Horth, D., Patel, B.Y., Ali, B., Spencer, T., Axelson, T., Kretzmer, L., Chhina, C., Anandarajah, C., Fautz, T., Horst, C., Thevathasan, A.A., Ng, J.Q., Hirst, F., Brewer, C.F., Logan, A.E., Lockey, J.W., Forrest, P.R., Keelty, N., Wood, A.D., Springford, L.R., Avery, P., Schulz, T.M., Bemand, T.P., Howells, L., Collier, H., Khajuria, A., Tharakan, R.G., Parsons, S., Buchan, A.M., McGalliard, R.J., Mason, J.D., Cundy, O.J., Li, N., Redgrave, N.A., Watson, R.P., Pezas, T.P., Dennis, Y.F., Segall, E., Hameed, M., Lynch, A.S., Chamberlain, M., Peck, F.S., Neo, Y.N., Russell, G., Elseedawy, M., Lee, S., Foster, N.L., Soo, Y.H., Puan, L., Dennis, R., Goradia, H., Qureshi, A., Osman, S., Reeves, T., Dinsmore, L., Marsden, M., Lu, Q., Pitts-Tucker, T., Dunn, C.E., Walford, R.A., Heathcote, E., Martin, R., Pericleous, A., Brzyska, K., Reid, K.G., Williams, M.R., Wetherall, N., McAleer, E., Thomas, D., Kiff, R., Milne, S., Holmes, M.J.V., Bartlett, J., Lucas de Carvalho, J., Bloomfield, T., Tongo, F., Bremner, R.H., Yong, N., Atraszkiewicz, B.A., Mehdi, A., Tahir, M., Sherliker, G.X.J., Tear, A.K., Pandey, A., Broyd, A., Omer, H.M., Raphael, M., Chaudhry, W.W., Shahidi, S., Jawad, A.S., Gill, C.K., Fisher, I. Hindle, Adeleja, I., Clark, I.J., Aidoo-Micah, G.E., Stather, P.W., Salam, G.J., Glover, T.E., Deas, G., Sim, N.K., Obute, R.D., Wynell-Mayow, W.M., Sait, M.S., Mitha, N., de Bernier, G.L., Siddiqui, M., Shaunak, R., Wali, A., Cuthbert, G., Bhudia, R., Webb, E., Shah, S., Ansari, N., Perera, M., Kelly, N., McAllister, R., Stanley, G.H., Keane, C.P., Shatkar, V., Maxwell-Armstrong, C., Henderson, L.A., Maple, N., Manson, R., Adams, R.D., Semple, E., Mills, M., Daoub, A., Marsh, A., Ramnarine, A., Hartley, J., Malaj, M., Jewell, P.D., Whatling, E.A., Hitchen, N., Chen, M., Goh, B., Fern, J., Rogers, S., Derbyshire, L., Robertson, D.T., Abuhussein, N., Deekonda, P., Abid, A., Harrison, P.L.M., Aildasani, L., Turley, H., Sherif, M.A., Pandey, G., Filby, J.J., Johnston, A., Burke, E., Mohamud, M., Gohil, K., Tsui, A.Y., Singh, R., Lim, S.J., O'Sullivan, K., McKelvey, L.L., O'Neill, S., Roberts, H.F., Brown, F.S., Cao, Y., Buckle, R.T., Liew, Y., Sii, S., Ventre, C.M., Graham, C.J., Filipescu, T., Yousif, A., Dawar, R., Wright, A., Peters, M., Varley, R., Owczarek, S., Hartley, S., Khattak, M., Iqbal, A., Ali, M., Durrani, B., Narang, Y., Bethell, G.S., Horne, L., Pinto, R., Nicholls, K., Kisyov, I., Torrance, H.D., English, W., Lakhani, S.M., Ashraf, S.F., Venn, M., Elangovan, V., Kazmi, Z., Brecher, J., Sukumar, S., Mastan, A., Mortimer, A., Parker, J., Boyle, J., Elkawafi, M., Beckett, J., Mohite, A., Narain, A., Mazumdar, E., Sreh, A., Hague, A., Weinberg, D., Fletcher, L., Steel, M., Shufflebotham, H., Masood, M., Sinha, Y., Jenvey, C., Kitt, H., Slade, R., Craig, A.R., Deall, C., Reakes, T., Chervenkoff, J., Strange, E., O'Bryan, M., Murkin, C., Joshi, D., Bergara, T., Naqib, S., Wylam, D., Scotcher, S.E., Hewitt, C.M., Stoddart, M.T., Kerai, A., Trist, A.J., Cole, S.J., Knight, C.L., Stevens, S., Cooper, G.E., Ingham, R., Dobson, J., O'Kane, A., Moradzadeh, J., Duffy, A., Henderson, C., Ashraf, S., McLaughin, C., Hoskins, T.C., Reehal, R.S., Bookless, L.R., McLean, R.C., Stone, E.J., Wright, E.V., Abdikadir, H.R., Roberts, C., Spence, O., Srikantharajah, M., Ruiz, E.M., Matthews, J.H., Gardner, E., Hester, E., Naran, P., Simpson, R., Minhas, M., Cornish, E., Semnani, S.A., Rojoa, D., Radotra, A., Eraifej, J., Eparh, K., Smith, D.N.E., Mistry, B.D., Hickling, S.L., Din, W., Liu, C., Mithrakumar, P., Mirdavoudi, V., Rashid, M., Mcgenity, C., Hussain, O., Kadicheeni, M., Gardner, H., Anim-Addo, N., Pearce, J., Aslanyan, A., Ntala, C., Sorah, T., Parkin, J., Alizadeh, M., White, A., Edozie, F., Johnston, J., Kahar, A., Navayogaarajah, V., Patel, B., Carter, D., Khonsari, P., Burgess, A., Kong, C., Ponweera, A., Cody, A., Tan, Y., Ng, A.Y.L., Croall, A., Allan, C., Ng, S., Raghuvir, V., Telfer, R., Greenhalgh, A.D., McKerr, C.N., Edison, M.A., Patel, B.A., Dear, K., Hardy, M.R., Williams, P., Hassan, S., Sajjad, U., O'Neill, E.M., Lopes, S., Healy, L., Jamal, N., Tan, S., Lazenby, D., Husnoo, S.B., Beecroft, S., Sarvanandan, T., Weston, C., Bassam, N., Rabinthiran, S., Hayat, U., Ng, L., Varma, D., Sukkari, M., Mian, A., Omar, A., Kim, J.W., Sellathurai, J., Mahmood, J., O'Connell, C., Bose, R., Heneghan, H., Lalor, P., Matheson, J., Doherty, C., Cullen, C., Cooper, D., Angelov, S., Drislane, C., Smith, A.C.D., Kreibich, A., Palkhi, E., Durr, A., Lotfallah, A., Gold, D., Mckean, E., Dhanji, A., Anilkumar, A., Thacoor, A., Siddiqui, Z.H., Lim, S., Piquet, A., Anderson, S.M., McCormack, D.R., Gulati, J., Ibrahim, A., Murray, S.E., Walsh, S.L., McGrath, A., Ziprin, P., Chua, E.Y., Lou, C.N., Bloomer, J., Paine, H.R., Osei-Kuffour, D., White, C.J., Szczap, A., Gokani, S., Patel, K., Malys, M.K., Reed, A., Torlot, G.E., Cumber, E.M., Charania, A., Ahmad, S., Varma, N., Cheema, H., Austreng, L., Petra, H., Chaudhary, M., Zegeye, M.I., Cheung, F., Coffey, D., Heer, R.S., Singh, S., Seager, E., Cumming, S., Suresh, R.S., Verma, S., Ptacek, I.B., Gwozdz, A.M., Yang, T., Khetarpal, A.A., Shumon, S., Fung, T.M.P., Leung, W., Kwang, P., Chew, L., Loke, W., Curran, A., Chan, C., McGarrigle, C., Mohan, K., Cullen, S., Wong, E., Toale, C., Collins, D., Keane, N., Traynor, B.P., Shanahan, D., Yan, A., Jafree, D.J., Topham, C., Mitrasinovic, S., Omara, S., Bingham, G., Lykoudis, P.M., Miranda, B.H., Whitehurst, K., Kumaran, G., Devabalan, Y., Aziz, H., Shoa, M., Dindyal, S., Yates, J.A., Bernstein, I., Rattan, G., Coulson, R., Stezaker, S., Isaac, A., Salem, M., McBride, A., McFarlane, H., Yow, L., MacDonald, J., Bartlett, R.D., Turaga, S., White, U., Liew, W., Yim, N., Ang, A., Simpson, A., McAuley, D., Craig, E., Murphy, L., Shepherd, P., Kee, J.Y., Abdulmajid, A., Chung, A., Warwick, H.L., Livesey, A., Holton, P., Theodoreson, M.D., Jenkin, S.L., Turner, J., Entwisle, J.H., Marchal, S.T., O'Connor, S., Blege, H.K., Aithie, J.M., Sabine, L.M., Stewart, G.E., Jackson, S., Kishore, A., Lankage, C.M., Acquaah, F., Joyce, H.L., McKevitt, K.L., Coffey, C.J., Fawaz, A.S., Dolbec, K.S., O'Sullivan, D.A., Geraghty, J.M., Lim, E., Bolton, L., FitzPatrick, D., Robinson, C., Ramtoola, T., Collinson, S., Grundy, L., McEnhill, P.M., Harbhajan Singh, G.S., Loughran, D., Golding, D.M., Keeling, R.E., Williams, R.P., Whitham, R.D.J., Yoganathan, S., Nachiappan, R., Egan, R.J., Owasil, R., Kwan, M.L., He, A., Goh, R.W., Bhome, R., Wilson, H., Teoh, P.J., Raji, K., Jayakody, N., Matthams, J., Chong, J., Luk, C.Y., Greig, R.J., Trail, M., Charalambous, G., Rocke, A.S., Gardiner, N., Bulley, F., Warren, N., Brennan, E., Fergurson, P., Wilson, R., Whittingham, H., Brown, E.J., Khanijau, R., Gandhi, K., Morris, S., Boulton, A.J., Chandan, N., Barthorpe, A.E., Maamari, R., Sandhu, S., McCann, M., Higgs, L., Balian, V., Reeder, C., Diaper, C., Sale, T., Ali, H., Archer, C.H., Clarke, A.K., Heskin, J., Hurst, P.C., Farmer, J.D., O'Flynn, L.D., Doan, L., Shuker, B.A., Stott, G.D., Vithanage, N.A., Hoban, K.A., Nesargikar, P.N., Kennedy, H.R., Grossart, C.M., Tan, E.S.M., Roy, C.S.D., Sim, P., Leslie, K.E., Sim, D., Abul, M.H., Cody, N., Tay, A.Y., Woon, E., Sng, S., Mah, J., Robson, J., Shakweh, E., Wing, V.C., Mills, H., Li, M.M., Barrow, T.R., Balaji, S., Jordan, H.E.M., Phillips, C., Naveed, H., Hirani, S., Tai, A., Ratnakumaran, R., Sahathevan, A., Shafi, A.M.A., Seedat, M., Weaver, R., Batho, A., Punj, R., Selvachandran, H., Bhatt, N., Botchey, S., Khonat, Z., Brennan, K., Morrison, C.J., Devlin, E., Linton, A., Galloway, E., McGarvie, S., Ramsay, N., McRobbie, H.D., Whewell, H., Dean, W., Nelaj, S., Eragat, M., Mishra, A., Kane, T., Zuhair, M., Wells, M., Wilkinson, D., Woodcock, N., Sun, E., Aziz, N., and Ghaffar, M. K. Abd
- Published
- 2019
- Full Text
- View/download PDF
155. Electron transport in T-shaped double quantum dot structure
- Author
-
Abbas, Mohammed A. A., Al-Badry, Lafy F., and Al-Khursan, Amin H.
- Published
- 2021
- Full Text
- View/download PDF
156. Microstructure and magnetic properties of FePt-(C,SiO2) granular films deposited on MgO, MgTiO, and MgTiON underlayers
- Author
-
Sepehri-Amin, H., Nagano, Miho, Seki, T., Ho, H., Tripathy, D., Pirzada, S., Srinivasan, K., Yuan, H., Dorsey, P., Ajan, A., and Hono, K.
- Published
- 2018
- Full Text
- View/download PDF
157. Coercivity and its thermal stability of Nd[sbnd]Fe[sbnd]B hot-deformed magnets enhanced by the eutectic grain boundary diffusion process
- Author
-
Li, J., Liu, Lihua, Sepehri-Amin, H., Tang, Xin, Ohkubo, T., Sakuma, N., Shoji, T., Kato, A., Schrefl, T., and Hono, K.
- Published
- 2018
- Full Text
- View/download PDF
158. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
- Author
-
Abdelhamid, N, Abdul Rahman, D, Abdul-Saheb, M, Abreu, P, Abroskina, M, Abu Ahmad, F, Accassat, S, Acciaresi, M, Adami, A, Ahmad, N, Ahmed, F, Alberto Hawkes, M, Alemseged, F, Ali, A, Altavilla, R, Alwis, L, Amarenco, P, Amaro, S, Amaya Sanchez, LE, Amelia Pinto, A, Ameriso, SF, Amin, H, Amino, T, Amjad, AK, Anagnostou, E, Andersen, G, Anderson, C, Anderson, DC, Andrea Falco, M, Andres Mackinnon, F, Andreu, D, Androulakis, M, Angel Gamero, M, Angel Saredo, G, Angeles Diaz, R, Angels Font, M, Anticoli, S, Arauz, A, Arauz Gongora, AA, Araya, P, Arenillas Lara, JF, Arias Rivas, S, Arnold, M, Augustin, S, Avelar, W, Azevedo, E, Babikian, V, Bacellar, A, Badalyan, K, Bae, HJ, Baez Martinez, EM, Bagelmann, H, Bailey, P, Bak, Z, Baker, M, Balazs, A, Baldaranov, D, Balogun, I, Balueva, T, Bankuti, Z, Bar, M, Baranowska, A, Bardutzky, J, Barker Trejo, S, Barlinn, J, Baronnet, F, Barroso, C, Barteys, M, Bartolottiova, T, Barulin, A, Bas, M, Bashir, S, Basile, V, Bathe-Peters, R, Bathula, R, Batista, C, Batur Caglayan, H, Baumgartner, P, Bazan, R, Bazhenova, O, Beaudry, M, Beer, J, Behnam, Y, Beilei, C, Beinlich, A, Bejot, Y, Belkin, A, Benavente, OR, Benjamin, A, Berardi, V, Bereczki, D, Berkowitz, SD, Berlingieri, J, Berrios, W, Berrouschot, J, Bhandari, M, Bhargavah, M, Bicker, H, Bicsak, T, Bilik, M, Bindila, D, Birchenall, J, Birnbaum, L, Black, T, Blacker, D, Blacquiere, D, Blanc-Labarre, C, Blank, C, Blazejewska-Hyzorek, B, Bloch, S, Bodiguel, E, Bogdanov, E, Boos, L, Borcsik, L, Bornstein, N, Bouly, S, Braga, G, Bragado, I, Bravi, MC, Brokalaki, C, Brola, W, Brouns, R, Bruce, D, Brzoska-Mizgalska, J, Buck, B, Buksinska-Lisik, M, Burke, J, Burn, M, Bustamante, G, Cabrejo, L, Cai, K, Cajaraville, S, Calejo, M, Calvet, D, Campillo, J, Campos Costa, E, Camps, P, Can Alaydin, H, Candeloro, E, Canepa, C, Cantu Brito, CG, Cappellari, M, Carcel, C, Cardona Portela, P, Cardoso, F, Carek, M, Carletti, M, Carlos Portilla, J, Caruso, P, Casado-Naranjo, I, Castellini, P, Castro, D, Castro Meira, F, Cavallini, A, Cayuela Caudevilla, N, Cenciarelli, S, Cereda, C, Cerrone, P, Chakrabarti, A, Chaloulos-Iakovidis, P, Chamorro, A, Chandrasena, D, Chang, DI, Che, C, Chembala, J, Chen, J, Chen, Z, Chen, T, Chen, H, Chen, X, Chen, G, Chen, L, Chen, S, Cheripelli, B, Chin, M, Chiquete Anaya, E, Chorazy, M, Christensen, H, Christensen, T, Christian, L, Chu, F, Chung, CS, Clark, W, Clarke, R, Claverie, S, Clemente Agostoni, E, Clissold, B, Coelho, J, Cohen, D, Colakoglu, S, Collas, D, Condurso, R, Connolly, SJ, Consoli, D, Constantin, C, Constantino Silva, AB, Contardo, L, Corlobe, A, Correia, M, Correia, C, Cortijo Garcia, E, Coull, B, Coutts, S, Coveney, S, Cras, P, Crols, R, Crozier, S, Csanyi, A, Csiba, L, Csontos, K, Csuha, R, Cui, L, Cunha, L, Curtze, S, Czerska, M, Czlonkowska, A, Czurko, M, Czuryszkiewicz, M, Dagnino, M, Dai, C, Daineko, A, Dalek, G, Damgaard, D, Danese, A, Dani, K, Danku, V, Dario Toledo, W, Dávalos, A, De Havenon, A, De Keyser, J, De Klippel, N, De La Torre, J, De Pauw, A, De Smedt, A, De Torres, R, De Vries Basson, MM, Dearborn, J, Deganutto, R, Degeorgia, M, Deguchi, I, Del Giudice, A, Delcourt, C, Delgado-Mederos, R, Della Marca, G, Delpont, B, Deltour, S, Demets, DL, Dennis, M, Desai, J, Devine, J, Dhollander, I, Di Mascio, MT, Diaconu, M, Diaz Otero, F, Dietzel, J, Diez-Tejedor, E, Ding, N, Ding, J, Diomedi, M, Dioszeghy, P, Distefano, M, Domigo, V, Dorodnicov, E, Dossi, D, Doubal, F, Druzenko, I, Du, P, Du, J, Duman, T, Duodu, Y, Dutta, D, Dylewicz, L, Eckstein, J, Ehrensperger, E, Ehrlich, S, Einer Allende, G, Elena Halac, B, Elyas, S, Endres, M, Engelbrecht, JM, Engelter, S, Epinat, M, Eren, F, Esbjornsson, M, Escribano, B, Escudero, I, Esisi, B, Essa, B, Esterbauer, M, Evans, N, Eveson, D, Fabio, S, Fang, L, Fanta, S, Fares, M, Fatar, M, Faust, K, Favate, A, Fazekas, F, Federica Denaro, M, Fedin, A, Felipe Amaya, P, Feng, J, Ferencova, K, Fernanda Gilli, M, Fernandez, MD, Fernandez Pirrone, PN, Fernandez Vera, J, Ferrari, J, Ferreira, A, Ferreira Junior, G, Fidler, M, Field, D, Field, T, Figueroa, C, Fiksa, J, Filipov, A, Firstenfeld, A, Fisch, L, Fischer, U, Fisselier, M, Fiszer, U, Fluri, F, Fortea, G, Fotherby, K, Fraczek, A, France, E, Freitas, G, Frey, S, Frick, M, Friedman, A, Friedrich, M, Frisullo, G, Fryze, W, Fuentes Gimeno, B, Fujigasaki, H, Fukuyama, K, Furlan, A, Furlanis, G, Furnace, J, Gabriel, M, Gabriel Reich, E, Gagliardi, RJ, Galati, F, Galli Giqueauk, E, Gallina, A, Gallinella, E, Gallo, J, Gangadharan, S, Gao, Y, Garcia Lopez, R, Garcia Pastor, A, Garcia Sanchez, SM, Garnauf, M, Garnier, P, Gasecki, D, Gasic, K, Gasiorek, K, Gasser, S, Gaugg, M, Gebreyohanns, M, Gebura, K, Geng, J, Geniz Clavijo, M, Georg Haeusler, K, Geran, R, Geremek, M, Gerocs, Z, Ghia, D, Giannandrea, D, Giatsidis, F, Gien Lopez, JA, Gil Nunez, A, Gimenez, L, Giralt, E, Glabinski, A, Gladstone, D, Gliem, M, Gluszkiewicz, M, Goddeau, R, Gogoleva, E, Gokce, M, Goldemund, D, Golikov, K, Gomes Neto, A, Gomez Schneider, M, Gomez-Choco, M, Gomis, M, Gongora-Rivera, JF, Gonysheva, Y, Gonzalez, L, Gonzalez Toledo, ME, Gottschal, M, Gozdzik, I, Grabowski, S, Graf, S, Green, D, Greer, D, Gregorio, T, Greisenegger, S, Greshnova, I, Griebe, M, Grzesik, M, Guan, J, Guarda, S, Gueguen, A, Guidoux, C, Guillermo Povedano, P, Guillon, B, Guiraudg, V, Gunathilagan, G, Guryanova, N, Gusev, V, Gustavo Persi, G, Gutiérrez, R, Guyler, P, Gyuker, N, Hachinski, V, Hajas, A, Hallevi, H, Hankey, G, Hankey, GJ, Hanouskova, L, Hao, L, Haraguchi, K, Haralur Sreekantaiah, Y, Haratz, S, Hargroves, D, Harkness, K, Harmel, P, Harrasser, M, Hart, RG, Harvey, M, Hasan, R, Hasegawa, Y, Hassan, A, Hattori, M, Hatzitolios, A, Hauk, M, Hayashi, T, Hayhoe, H, Hedna, VS, Heine, M, Held, V, Hellwig, S, Henkner, J, Henninger, N, Hermans, S, Hernandez, J, Herrero, D, Hervieu-Begue, M, Herzig, R, Hicken, L, Hieber, M, Hill, M, Hirose, M, Hobeanu, MC, Hobson, B, Hochstetter, M, Hoe Heo, J, Hoffmann, M, Holmstedt, C, Hon, P, Hong, KS, Honma, Y, Horev, A, Horgan, G, Horvath, L, Horvath, M, Hoyer, C, Huang, D, Huang, H, Huber, B, Huhtakangas, J, Hussain, M, Igarashi, S, Iglesias Mohedano, AM, Ignacio Tembl, J, Impellizzeri, M, Inanc, Y, Ioli, P, Irina Aniculaesei, A, Ishida, K, Itabashi, R, Iversen, H, Jagolino, A, Jakab, K, Jander, S, Janka, H, Jankovych, J, Jansen, J, Jasek, L, Javier Alet, M, Javor, L, Jin, X, Jing, P, Joachim, B, Joan Macleod, M, Johnson, M, Jose Martin, J, Joyner, C, Judit Szabo, K, Jun-Oconnell, A, Jura, R, Kaczorowska, B, Kadlcikova, J, Kahles, T, Kakaletsis, N, Kakuk, I, Kalinowska, K, Kaminska, K, Kaneko, C, Kanellos, I, Kapeller, P, Kapica-Topczewska, K, Karasz, O, Karlinski, M, Karlsson, JE, Kasa, K, Kashaeva, E, Kasner, SE, Kaste, M, Kasza, J, Katalin Iljicsov, A, Katsurayama, M, Kaur, S, Kawanishi, M, Kaygorodtseva, S, Ke, K, Kei, A, Keilitz, J, Kellner, J, Kelly, P, Kelly, S, Kemlink, D, Kerekgyarto, M, Keskinarkaus, I, Khairutdinova, D, Khanna, A, Khaw, A, Kholopov, M, Khoumri, C, Kirpicheva, S, Kirshner, H, Kitagawa, K, Kittner, S, Kivioja, R, Klein, F, Kleindorfer, D, Kleinig, T, Klivenyi, P, Knecht, S, Kobayashi, Y, Kobayashi, A, Koch, M, Koehler, L, Koivu, M, Kolianov, V, Koltsov, I, Kondo, T, Konkov, I, Kopecky, S, Korompoki, E, Korpela, J, Kosarz-Lanczek, K, Koutroubi, A, Kovacs, K, Kovacs, T, Kovacs, H, Kowalczyk, K, Kowalska, M, Krajickova, D, Kral, M, Krarup Hansen, C, Kraska, J, Krebs, S, Krejci, V, Kremer, C, Kreuzpointer, R, Krzyzanowska, M, Kucken, D, Kulakowska, A, Kunzmann, J, Kurenkova, N, Kuris, A, Kurkowska-Jastrzebska, I, Kurtenkova, N, Kurushina, O, Kusnick, G, Kustova, M, Kuwashiro, T, Kwan Cha, J, Lago, A, Lagutenko, M, Lajos, B, Lambeck, J, Lamy, C, Landolfi, A, Lanfranconi, S, Lang, W, Lara Lezama, LB, Lara Rodriguez, B, Largo, T, Lasek-Bal, A, Latte, L, Lauer, V, Lavados, P, Le Bouc, R, Leal Cantu, R, Lechner, H, Lecouturier, K, Leder, S, Lee, J, Lee, BC, Leger, A, Leira, E, Leisse, I, Leker, R, Lembo, G, Lenskaya, L, Leyden, J, Li, G, Li, M, Li, S, Li, J, Liamis, G, Liang, H, Liang, Z, Ligot, N, Lin, H, Lindert, R, Lindgren, A, Linna, M, Litwin, T, Liu, K, Liu, X, Llull, L, Lohninger, B, Longoni, M, Loomis, C, Lopes, D, Lopez Fernandez, M, Lopez Garza, N, Lord, A, Louw, S, Lovasz, R, Lowenkopf, T, Lu, Z, Lubke-Detring, SC, Luder, R, Lujan, S, Luo, B, Lupinogina, L, Luschin, G, Lutsep, H, Lvova, A, Ly, J, Grosse, G.M., Ma, H, Ma, C, Machado, M, Machado, C, Macher, S, Machetanz, J, Macian-Montoro, F, Mackey, E, Mackey, A, Maclean, G, Maestre-Moreno, J, Magadan, A, Magyar, T, Mahagney, A, Majid, A, Majjhoo, A, Makaritsis, K, Mandzia, J, Mangas Guijarro, M, Mangion, D, Manios, E, Mann, S, Manning, L, Manno, C, Manuel Garcia, J, Maqueda, V, Mar Castellanos, M, Mar Freijo, M, Marando, C, Marcela Lepera, S, Marcos Couto, J, Maria Bruera, G, Maria Greco, L, Maria Lorenzo, A, Maria Obmann, S, Maria Roa, A, Marini, C, Marinkovic, I, Mario Sumay, G, Mario Torres, C, Marko, M, Markova, S, Markus, H, Marsh, R, Marsili, E, Marta Esnaola, M, Marta Moreno, J, Marti-Fabregas, J, Martina Angelocola, S, Martínez Sánchez, P, Martinez-Majander, N, Martins, S, Marzelik, O, Mastrocola, S, Matamala, G, Matoltsy, A, Matosevic, B, Matsumoto, S, Maud, A, Mauri Cabdevila, G, May, Z, Mayasi, Y, Mayr, A, Mazzoli, T, Mcarthur, K, Mccullough, L, Medina Pech, CE, Medlin, F, Mehdiratta, M, Mehta, S, Mehta, D, Mehta, B, Melis, M, Melnikova, E, Mendez, B, Mendonca, T, Mengual Chirifie, JJ, Menon, N, Mensch, A, Meseguer, E, Messe, S, Metcalf, K, Meyer, N, Michas, F, Micheletti, N, Mikulik, R, Milionis, H, Miller, B, Milling, T, Minelli, C, Minhas, J, Minns, M, Mircea, D, Mishra, S, Mismas, A, Mistri, A, Mitrovic, N, Miyake, H, Modrau, B, Moey, A, Molina, C, Molina, J, Molis, A, Moller, J, Molnar, S, Moniche, F, Monosi, C, Monzani, V, Moonis, M, Morais, R, Morales, L, Morales, A, Morar-Precup, D, Moreton, F, Moro, C, Morozova, E, Morton, M, Morvan, T, Morvan, E, Motko, T, Mowla, A, Mozhejko, E, Muddegowda, G, Mudhar, O, Mueller, T, Muhl, C, Muir, KW, Mundl, H, Munoz, S, Murphy, C, Murphy, S, Murtuzova, A, Musuka, T, Mutzenbach, J, Myint, M, Mysliwy, W, Naccarato, M, Naeije, G, Nagakane, Y, Natarajan, I, Navaratnam, D, Nave, A, Nazliel, B, Nedeltchev, K, Nel, J, Nell, H, Nemeth, R, Nemeth, L, Neto, O, Ng, K, Ngeh, J, Nicolas Chialvo, L, Nieminen, T, Nikkanen, M, Nikl, J, Nikoforova, M, Nishino, S, Nishiyama, Y, Njovane, X, Nogawa, S, Nombela, F, Norrving, B, Nosek, K, Nowak, B, Nowakowska-Sledz, E, Ntaios, G, Numminen, H, Nunez, F, Obadia, M, Oberndorfer, S, Obrezan, A, Ochiai, J, Oczkowski, W, O'Donnell, MJ, Odyniec, A, Oh, K, Ohira, M, Okamoto, Y, Okpala, M, Okubo, S, Olah, L, Olavarria, V, Oleszek, J, Onat Demirci, N, Ondar, V, Ongun, G, Ooyama, K, Orosz, V, Ortiz, R, Osseby, G, Österlund-Tauriala, E, Ovesen, C, Ozcekic Demirhan, S, Ozdoba-Rot, J, Ozturk, S, Ozyurt, E, Pablo Grecco, M, Pablo Povedano, G, Paciaroni, M, Padiglioni, C, Pagola, J, Palasik, W, Panczel, G, Panos, L, Papadopoulos, G, Papadopoulou, E, Papagiannis, A, Papavasileiou, V, Papina, M, Pardo De Donlebun, JR, Parisi, V, Park, JM, Pasten, J, Patel, N, Pavlik, O, Pawelczyk, M, Peacock, WF, Pei, H, Peisker, T, Pena Sedna, LF, Penn, A, Pentek, S, Pepper, E, Pereira, L, Perera, K, Perez, Y, Perez, S, Perez Leguizamon, P, Pernicka, M, Perry, R, Persico, A, Pesant, Y, Peska, S, Peters, D, Peters, G, Pettigrew, L, Phan, T, Philippi, S, Phinney, T, Pico, F, Pidal, A, Piechowski-Jozwiak, B, Pieroni, A, Pineiro, S, Piras, V, Pizova, N, Polanco, J, Polin, M, Polyakov, A, Polychronopoulou, E, Polymeris, A, Popov, D, Poppe, A, Postorino, P, Pozzerese, C, Pradhan, M, Prats, L, Prazdnichkova, E, Prendl, B, Pretorius, M, Profice, P, Prokopenko, S, Pudov, E, Pujol Lereis, V, Punzo Bravo, G, Purroy, F, Qiu, J, Qu, X, Quenardelle, V, Quesada Garcia, H, Radrizzani, L, Radtke, A, Raffelsberger, T, Ramirez Moreno, JM, Ramos-Estebanez, C, Rani, A, Rapantova, P, Rashed, K, Rasheed Nihara, A, Rasmussen, J, Redondo Robles, L, Reif, M, Reiner, P, Rekova, P, Renu, A, Repetto, M, Reyes, P, Reyes Morales, S, Rha, JH, Ribeiro, J, Ricci, S, Richard, C, Rigual, R, Rinaldi, C, Riveira Rodriguez, C, Rizzato, B, Robinson, TG, Rocco, A, Rodrigues, M, Rodriguez, G, Rodriguez Campello, A, Rodriguez Lucci, F, Rodriguez Yanez, M, Roesler, C, Roffe, C, Roine, R, Roine, S, Roldan, A, Romana Pezzella, F, Romano, M, Roos, JS, Rosso, C, Rostrup Kruuse, C, Roth, Y, Roukens, R, Roveri, L, Rozanski, D, Rozniecki, J, Rozsa, C, Rudilosso, S, Ruiz Ares, G, Ruiz Franco, A, Rum, G, Ruuskanen, J, Rybinnik, I, Ryota, K, Saarinen, J, Saavedra, V, Sabben, C, Sabet, A, Sagris, D, Sahlas, J, Sakai, N, Salamanca, P, Salgado, P, Salig, S, Salletmayr, T, Salnikov, M, Samoshkina, O, Samson, Y, Sanak, D, Sànchez Cerón, M, Santalucia, P, Santamaria Cadavid, M, Santiago, P, Santo, G, Sanz Cuesta, B, Sargento, J, Sarraj, A, Sas, K, Sas, A, Satoshi, O, Satsoglou, S, Sattar, N, Savitz, S, Savopoulos, C, Saw, J, Sawicka, M, Sawyer, R, Scandura, T, Schillinger, N, Schindler, J, Schlachetzki, F, Schneider, I, Schuppner, R, Schurig, J, Schwarzbach, CJ, Sebejova, M, Seidel, G, Sekaran, L, Selcuk, D, Selvarajah, J, Semerano, A, Semjen, J, Semushina, D, Sen, S, Seok Park, M, Serena, J, Serhat Tokgoz, O, Serles, W, Serrano, F, Sevin, M, Seynaeve, L, Shah, S, Shamalov, N, Shang, T, Sharma, M, Sharrief, A, Shazam Hussain, M, Shchukin, I, Shen, W, Shepeleva, E, Shinsuke, I, Shmonin, A, Shoamanesh, A, Shuaib, A, Shulga, A, Sibolt, G, Sibon, I, Sicilia, I, Siebert, M, Sieczkowska, E, Sila, C, Silva, AA, Silva, D, Silva, P, Silva, Y, Silvestrini, M, Simony, Z, Simpkins, A, Singh, B, Sinha, D, Sipos, I, Skoda, O, Skowron, P, Skowronska, M, Sliwinska, B, Slonkova, J, Smolkin, A, Smyth, A, Sobolewski, P, Sobota, A, Sohn, SI, Soldatov, M, Solganov, I, Soloveva, L, Solovyeva, E, Sonntag, N, Soors, P, Sorgun, M, Soriano, C, Spence, D, Spengos, K, Sposato, L, Staaf, G, Stadler, K, Stakhovskaya, L, Stamatelopoulos, K, Steinert, S, Stetkarova, I, Stiehm, M, Stocker, R, Stoinski, J, Stoll, A, Stotts, G, Stumpp, A, Sucapane, P, Suenaga, T, Sun, X, Sundararajan, S, Sung Kim, J, Suzuki, H, Svaneborg, N, Szasz, G, Szczuchniak, W, Szczyrba, S, Szegedi, N, Szekely, A, Szewczyk, Z, Szilagyi, G, Szlufik, S, Szoboszlai, K, Szpisjak, L, Sztajzel, R, Sztriha, L, Ta Wil, SE, Taggeselle, J, Takamatsu, K, Takao, M, Taki, W, Takizawa, S, Talahma, M, Tamayo, A, Tan, J, Tanne, D, Tapanainen, A, Tapiola, T, Tarasiuk, J, Tatlisumak, T, Tayal, A, Tcvetkova, S, Teal, P, Tejada Garcia, J, Tejada Meza, H, Tenora, D, Terceno, M, Terentiou, A, Tezcan, S, Thaler, D, Thomson, A, Thouvenot, E, Tiainen, M, Timberg, I, Timsit, S, Tinchon, A, Tirschwell, D, Togay Isikay, C, Tokunaga, K, Tolino, M, Toloza, C, Tomelleri, G, Tomoyuki, K, Tomppo, LM, Tong, Z, Tong, L, Toni, D, Torres, J, Tossavainen, C, Toth, G, Tountopoulou, A, Touze, E, Tovar, M, Toyoda, K, Trillo, S, Trommer, A, Tropepi, D, Tryambake, D, Tu, H, Tuetuencue, S, Tumova, R, Tumpula, O, Turc, G, Tutaj, A, Tynkkynen, J, Uchiyama, S, Uchwat, U, Uhrinyakova, L, Ulku Acar, R, Uluduz Ugurlu, D, Urra, X, Urui, S, Usero Ruiz, M, Vaclavik, D, Vahedi, K, Valikovics, A, Valpas, J, Van Acker, P, Van Daele, W, Vanderschueren, G, Vanina Jure, L, Varela, R, Varga, Z, Varvat, J, Varvyanskaya, N, Vasco Salgado, A, Vasko, P, Vass, L, Vassilopoulou, S, Vastagh, I, Vazquez, P, Vecsei, L, Veltkamp, R, Venti, M, Verdugo, M, Verocai, V, Veronica Marroquin, M, Veronica Simonsini, C, Veverka, T, Vigl, M, Vila, A, Vilar, C, Villanueva Osorio, JA, Virta, J, Vitkova, E, Voglsperger, B, Volna, J, Von Weitzel-Mudersbach, PA, Vora, N, Voznyuk, I, Wach-Klink, A, Wacongne, A, Walters, D, Wang, Y, Wang, J, Wang, L, Wang, X, Wang, W, Wang, N, Wang, D, Wang, H, Warnack, W, Wartenberg, K, Waters, R, Waters, M, Webb, T, Weber, J, Weiss, G, Weissenborn, K, Weitz, JI, Weller, B, Wen, G, Weng, G, Werner, P, Werring, D, Wester, P, Whiteley, W, Whiting, R, Wijeratne, T, Willems, C, Wilson, L, Wilson, C, Winder, T, Windt, J, Winkler, A, Winska-Tereszkiewicz, A, Wisniewska, A, Wittayer, M, Wlodek, A, Wojnarowska-Arendt, A, Wolf, M, Wolff, V, Wolter, C, Wong, A, Wook Nah, H, Worthmann, H, Wu, W, Wu, S, Wunderlich, S, Wurzinger, H, Wyse, DG, Xiao, B, Xiaopeng, W, Ximenez-Carrillo, A, Xiong, L, Xiong, Y, Xiong, W, Xu, Y, Xu, J, Xu, Z, Yalo, B, Yamada, T, Yamasaki, M, Yang, L, Yang, Y, Yang, X, Yang, Q, Yang, B, Yang, J, Yasuhiro, I, Yee Lam, M, Yegappan, C, Yip, S, Ylikallio, E, Ylikotila, P, Yongwon Jin, A, Yoon, BW, Yoshida, Y, Yperzeele, L, Yuan, H, Yuasa, H, Zalewska, J, Zanferrari, C, Zapata, E, Zboznovits, D, Zelenka, I, Zhang, C, Zhang, B, Zhang, S, Zhang, M, Zhang, X, Zhang, J, Zhao, L, Zhirnova, O, Zhou, L, Zielinska-Turek, J, Zinchenko, I, Ziomek, M, Zitzmann, A, Zweifler, R, Zwiernik, J, Kasner, Scott E, Swaminathan, Balakumar, Lavados, Pablo, Sharma, Mukul, Muir, Keith, Veltkamp, Roland, Ameriso, Sebastian F, Endres, Matthias, Lutsep, Helmi, Messé, Steven R, Spence, J David, Nedeltechev, Krassen, Perera, Kanjana, Santo, Gustavo, Olavarria, Veronica, Lindgren, Arne, Bangdiwala, Shrikant, Shoamanesh, Ashkan, Berkowitz, Scott D, Mundl, Hardi, Connolly, Stuart J, and Hart, Robert G
- Published
- 2018
- Full Text
- View/download PDF
159. B0.1In0.9P Quantum Dot Semiconductor Optical Amplifiers.
- Author
-
Almosawi, Buraq T. Sh., Al-Hashimi, Mohammed K., Al-Nashy, Baqer Obaid, and Al-Khursan, Amin H.
- Abstract
The modal gain of the undoped and doped B 0.1 In 0.9 P / GaP and B 0.1 In 0.9 P / BP quantum dot (QD) structures are studied due to their importance, especially in Si-based devices. The first structure has three peaks, while the second structure has two peaks, where the first excited state (ES) peak is contained in the ground state (GS) one. The second ES peak is the highest for both structures. The B 0.1 In 0.9 P / GaP structure has a dip absorption results from the fourth state transition, peaked at 765 nm wavelength and covers the wavelength spectrum 600 - 2480 nm . The modal gain of B 0.1 In 0.9 P / BP QD structure doubles the other structure, peaked at 775 nm , and its spectrum covers 600 - 1360 nm . The difference in the bandwidth of their spectra comes from the bandgap difference of their barriers. In both structures, doping changes the spectrum from absorption to gain, indicating its high importance in increasing gain. For these two structures as QD semiconductor optical amplifiers (QDSOAs), the signal gain is increased by two orders compared to Sb-based QDSOAs and by one order compared to InGaAs / GaAs QDSOAs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
160. Epigenomic signatures as circulating and predictive biomarkers in sarcomatoid renal cell carcinoma
- Author
-
El Zarif, Talal, primary, Semaan, Karl, additional, Eid, Marc, additional, Sep, Ji-Heui, additional, Semaan, Simon Garinet, additional, Davidsohn, Matthew P., additional, Fortunato, Brad, additional, Canniff, John, additional, Nassar, Amin H., additional, Abou Alaiwi, Sarah, additional, Bakouny, Ziad, additional, Lakshmi, Gitanjali, additional, Savigano, Hunter, additional, Lyons, Kevin, additional, Matar, Sayed, additional, Ali, Atef, additional, Saad, Eddy, additional, Saliby, Renee Maria, additional, Cordeiro, Paulo, additional, Zhang, Ziwei, additional, El Ahmar, Nourhan, additional, Nabil Laimon, Yasmine, additional, Labaki, Chris, additional, Shah, Valisha, additional, Freeman, Dory, additional, O'Toole, Jillian, additional, Lee, Gwo-Shu Mary, additional, Hwang, Justin, additional, Pomerantz, Mark, additional, Signoretti, Sabina, additional, Xie, Wanling, additional, Berchuck, Jacob E., additional, Viswanathan, Srinivas R., additional, Van Allen, Eliezer M., additional, Braun, David A., additional, Choueiri, Toni K., additional, Freedman, Matthew L., additional, and Baca, Sylvan C., additional
- Published
- 2023
- Full Text
- View/download PDF
161. Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade: a systematic review and meta-analysis of randomised controlled trials
- Author
-
Fujiwara, Yu, primary, Horita, Nobuyuki, additional, Adib, Elio, additional, Zhou, Susu, additional, Nassar, Amin H, additional, Asad, Zain UL Abideen, additional, Cortellini, Alessio, additional, and Naqash, Abdul Rafeh, additional
- Published
- 2023
- Full Text
- View/download PDF
162. Optical gain of CdxZn1−xTe quantum dot structures
- Author
-
Abdullah, Muwaffaq, primary, Al‐Nashy, Baqer O., additional, and Al‐Khursan, Amin H., additional
- Published
- 2023
- Full Text
- View/download PDF
163. Relationships between sleep patterns and metabolic profile in patients maintained on antipsychotics: a cross-sectional comparative study
- Author
-
Kiwan N, Mahfoud Z, Ghuloum S, Yehya A, Hammoudeh S, Hani Y, Chamali R, Amro I, Mook-Kanamori D, and Al-Amin H
- Subjects
sleep duration ,sleep quality ,metabolic syndrome ,mental disorders ,antipsychotics. ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Nancy Kiwan,1 Ziyad Mahfoud,2,3 Suhaila Ghuloum,4 Arij Yehya,1 Samer Hammoudeh,1 Yahya Hani,4 Rifka Chamali,1 Iman Amro,1 Dennis Mook-Kanamori,5 Hassen Al-Amin61Department of Research, Weill Cornell Medicine - Qatar, Doha, Qatar; 2Department of Health Policy and Research, Weill Cornell Medicine - Qatar, Doha, Qatar; 3Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, USA; 4Psychiatry Hospital, Hamad Medical Corporation, Doha, Qatar; 5Department of Physiology and Biophysics, Weill Cornell Medicine - Qatar, Doha, Qatar; 6Department of Psychiatry, Weill Cornell Medicine - Qatar, Doha, QatarBackground: Disturbances in sleep duration and quality have been associated with obesity and other metabolic changes. Patients with mental disorders (MD) are known to have more sleep problems, and antipsychotics (AP), used in the treatment of these patients, can also cause weight gain. This study aimed to compare the self-reported sleep patterns between psychiatric patients (on or off AP) and controls. We also evaluated the associations between the clinical and metabolic profiles with short or long sleep duration.Methods: A total of 339 subjects was recruited: Mentally ill patients maintained on AP for at least six months (MD+AP, n=112), patients not taking AP for at least the last six months before enrollment (MD/noAP, n=101), and non-psychiatry controls (HC, n=126). Multinomial regression analysis was applied to find the predictors of irregular sleep duration in this sample.Results: More mentally ill patients (MD+AP and MD/noAP) reported a sleep duration of >8 hrs than HC. Patients from MD/noAP showed more insomnia than HC. Sleep disturbances were significantly more frequent in MD+AP than HC. Participants who reported sleeping >8 hrs had higher body mass index and waist circumference than those who slept 8h) in the population of Qatar.Keywords: sleep duration, sleep quality, metabolic syndrome, mental disorders, antipsychotics
- Published
- 2019
164. Trans-ethnic variation in germline variants of patients with renal cell carcinoma
- Author
-
Sarah Abou Alaiwi, Amin H. Nassar, Elio Adib, Stefan M. Groha, Elie W. Akl, Bradley A. McGregor, Edward D. Esplin, Shan Yang, Kathryn Hatchell, Vincent Fusaro, Sarah Nielsen, David J. Kwiatkowski, Guru P. Sonpavde, Mark Pomerantz, Judy E. Garber, Matthew L. Freedman, Huma Q. Rana, Alexander Gusev, and Toni K. Choueiri
- Subjects
renal cell carcinoma ,kidney cancer ,germline variants ,DNA damage repair ,clinical genetics ,Ancestry ,Biology (General) ,QH301-705.5 - Abstract
Summary: Prior studies of the renal cell carcinoma (RCC) germline landscape investigated predominantly patients of European ancestry. We examine the frequency of germline pathogenic and likely pathogenic (P/LP) variants in 1,829 patients with RCC from various ancestries. Overall, P/LP variants are found in 17% of patients, among whom 10.3% harbor one or more clinically actionable variants with potential preventive or therapeutic utility. Patients of African ancestry with RCC harbor significantly more P/LP variants in FH compared to patients of non-African ancestry with RCC and African controls from the Genome Aggregation Database (gnomAD). Patients of non-African ancestry have significantly more P/LP variants in CHEK2 compared to patients of African ancestry with RCC and non-Finnish Europeans controls. Non-Africans with RCC have more actionable variants compared to Africans with RCC. This work helps understand the underlying biological differences in RCC between Africans and non-Africans and paves the way to more comprehensive genomic characterization of underrepresented populations.
- Published
- 2021
- Full Text
- View/download PDF
165. Double quantum dot–metal nanoparticle systems under strong coupling.
- Author
-
Akram, Haneen, Abdullah, M., and Al-Khursan, Amin H.
- Subjects
QUANTUM dots ,MOLECULAR spectra ,INDUCTIVE effect ,ENERGY policy ,PLASMONICS ,POLARITONS - Abstract
This work uses the Green function to model the emission spectra from a hybrid metal nanoparticle (MNP) coupled with a double quantum dot (DQD), considering higher-order plasmonic mode contribution. It calculates the quantum dot (QD) energy states and momenta, i.e., this work differs from other strong-coupling systems by considering the material entities. A Fano-shape spectrum is shown with peaks depending on interference between the fields with the DQD and MNP. A prominent effect of the pump field appears as it interferes with other fields (probe and MNP polarization field). The MNP–DQD distance and MNP radius control the peak height and its position in the spectrum. The importance of the probe field in controlling the peak frequency and its height is demonstrated. The transition energy with momenta controls the spectra. An approximated relation is presented. High strength in the DQD–MNP and a more strong contribution are obtained compared to QD–MNP. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
166. Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes
- Author
-
Nuzzo, Pier Vitale, Berchuck, Jacob E., Korthauer, Keegan, Spisak, Sandor, Nassar, Amin H., Abou Alaiwi, Sarah, Chakravarthy, Ankur, Shen, Shu Yi, Bakouny, Ziad, Boccardo, Francesco, Steinharter, John, Bouchard, Gabrielle, Curran, Catherine R., Pan, Wenting, Baca, Sylvan C., Seo, Ji-Heui, Lee, Gwo-Shu Mary, Michaelson, M. Dror, Chang, Steven L., Waikar, Sushrut S., Sonpavde, Guru, Irizarry, Rafael A., Pomerantz, Mark, De Carvalho, Daniel D., Choueiri, Toni K., and Freedman, Matthew L.
- Published
- 2020
- Full Text
- View/download PDF
167. Reboiler pinch: An approach to optimize flare system design during FEED
- Author
-
Amin, H., Dhote, P., and Kanade, S.
- Subjects
Petroleum refineries -- Design and construction -- Production processes ,Gas flares -- Control ,Process control -- Methods ,Business ,Petroleum, energy and mining industries - Abstract
A process plant's pressure relief and flare systems are critical safety elements. Efficient design, management and maintenance of suitable pressure relief and flare systems are vital to operations throughout the [...]
- Published
- 2020
168. Reprint of Prospect for HRE-free high coercivity Nd-Fe-B permanent magnets
- Author
-
Hono, K. and Sepehri-Amin, H.
- Published
- 2018
- Full Text
- View/download PDF
169. Microstructure of a Dy-free Nd-Fe-B sintered magnet with 2 T coercivity
- Author
-
Xu, X.D., Sasaki, T.T., Li, J.N., Dong, Z.J., Sepehri-Amin, H., Kim, T.H., Ohkubo, T., Schrefl, T., and Hono, K.
- Published
- 2018
- Full Text
- View/download PDF
170. In situ small-scale hydrogen embrittlement testing made easy: An electrolyte for preserving surface integrity at nano-scale during hydrogen charging
- Author
-
Hajilou, Tarlan, Hope, Malin S.B., Zavieh, Amin H., Kheradmand, Nousha, Johnsen, Roy, and Barnoush, Afrooz
- Published
- 2018
- Full Text
- View/download PDF
171. Prospect for HRE-free high coercivity Nd-Fe-B permanent magnets
- Author
-
Hono, K. and Sepehri-Amin, H.
- Published
- 2018
- Full Text
- View/download PDF
172. Intrinsic magnetic properties of Sm(Fe1-xCox)11Ti and Zr-substituted Sm1-yZry(Fe0.8Co0.2)11.5Ti0.5 compounds with ThMn12 structure toward the development of permanent magnets
- Author
-
Tozman, P., Sepehri-Amin, H., Takahashi, Y.K., Hirosawa, S., and Hono, K.
- Published
- 2018
- Full Text
- View/download PDF
173. Suppression of non-oriented grains in Nd-Fe-B hot-deformed magnets by Nb doping
- Author
-
Tang, Xin, Sepehri-Amin, H., Ohkubo, T., and Hono, K.
- Published
- 2018
- Full Text
- View/download PDF
174. Microstructural origin of hysteresis in Ni-Mn-In based magnetocaloric compounds
- Author
-
Sepehri-Amin, H., Taubel, A., Ohkubo, T., Skokov, K.P., Gutfleisch, O., and Hono, K.
- Published
- 2018
- Full Text
- View/download PDF
175. Coercivity enhancement of hot-deformed Ce-Fe-B magnets by grain boundary infiltration of Nd-Cu eutectic alloy
- Author
-
Tang, Xin, Sepehri-Amin, H., Ohkubo, T., Yano, M., Ito, M., Kato, A., Sakuma, N., Shoji, T., Schrefl, T., and Hono, K.
- Published
- 2018
- Full Text
- View/download PDF
176. Effects of enamel matrix derivative components on PDL cell differentiation
- Author
-
Amin, H. D.
- Subjects
570 - Abstract
Previous studies have reported that the adult periodontal ligament (PDL) may contain progenitor/stem cells that function as precursors for periodontal tissue regeneration, although the ability of this population to differentiate into the multiple lineages present in the PDL is not yet certain. In addition, although Enamel Matrix Derivative (EMD; Emdogain®), derived from the enamel matrix of developing teeth) has been used extensively to help re-build new periodontal tissue, its effect on bone regeneration remains inconclusive and its effect on PDL blood vessels and nerve cell development not yet known, because it comprises a heterogeneous mixture of proteins. EMD has recently been separated into two main fractions: Fraction C, containing proteins < 6 kDa (mainly the tyrosine-rich amelogenin peptide TRAP); and Fraction A, containing proteins > 6 KDa (including the full-length amelogenin, sheathlins and a leucine-rich amelogenin peptide LRAP). The present study examined the effects of EMD Fractions on multi-lineage differentiation pathays of PDL cells in vitro. The results of the present study have shown that that Fraction C and Fraction A differentially regulate multilineage specification of PDL cells. Thus, Fraction C was found to up-regulate chondrogenic, vasculogenic, angiogenic, neurogenic and gliogenic genes and ‘terminal’ differentiation, whereas Fraction A was found to stimulate osteogenic genes and terminal osteogenic differentiation in vitro; both fractions suppressed adipogenesis. Moreover, the TRAP and LRAP peptides of Fraction C and Fraction A, respectively, were found to be at least partly responsible for the differential activities of these two fractions. In addition, at least some components in these EMD Fractions bound to and were internalized into PDL cells, most probably by receptor-mediated endocytosis. These findings thus demonstrate that the PDL contains cells with multi-lineage differentiation potential and that the components of EMD have differential effects on the diverse activities on the heterogeneous cells present in the PDL.
- Published
- 2011
177. Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas
- Author
-
Goodman, Aaron M., Holden, Kimberly A., Jeong, Ah-Reum, Kim, Lisa, Fitzgerald, Kerry D., Almasri, Eyad, McLennan, Graham, Eisenberg, Marcia, Jahromi, Amin H., Hoh, Carl, Hurley, Michael, Mulroney, Carolyn, Tzachanis, Dimitrios, Ball, Edward D., Jensen, Taylor J., and Kurzrock, Razelle
- Published
- 2022
- Full Text
- View/download PDF
178. Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes
- Author
-
Matthew Mossanen, Amin H. Nassar, Samantha M. Stokes, Nieves Martinez-Chanza, Vivek Kumar, Pier Vitale Nuzzo, David J. Kwiatkowski, Judy E. Garber, Catherine Curran, Dory Freeman, Mark Preston, Kent W. Mouw, Adam Kibel, Toni K. Choueiri, Guru Sonpavde, and Huma Q. Rana
- Subjects
Germ Cells ,Urinary Bladder Neoplasms ,Oncology ,Incidence ,Urology ,Humans ,Genetic Predisposition to Disease ,Germ-Line Mutation ,Retrospective Studies - Abstract
The familial aggregation of bladder cancers has been observed, but the incidence and association of familial bladder cancer with germline pathogenic and likely pathogenic (P/LP) variants is unknown.A retrospective analysis was conducted of patients with bladder cancer treated at the Dana-Farber Cancer Institute to identify those with a first-degree relative with bladder cancer. A second cohort of patients referred to DFCI for suspicion of a cancer predisposition syndrome was analyzed for candidate P/LP germline variants. Descriptive statistics were generated.Among 885 patients with bladder cancer, 38 patients (4.3%) had a family history of bladder cancer in a first-degree relative. No significant association of age of diagnosis was observed between patients with and without a first-degree family history of bladder cancer (P = .3). In the second cohort, 27 of 80 (34%) patients with bladder cancer evaluated for cancer predisposition syndromes harbored a P/LP germline variant. P/LP variants were identified most commonly in the following genes: BRCA1 (n = 5), MSH2 (n = 5), MLH1 (n = 4), ATM (n = 3), and CHEK2 (n = 2). Of the 27 patients with identified germline P/LP variants, 20 (74%) had a family history of a tumor component syndrome in a first- or second-degree relative and 3 were subsequently diagnosed with another genetically-linked associated cancer.Familial bladder cancer defined as bladder cancer in the proband and a first-degree relative, was present in 4.3% of patients with bladder cancer and was not associated with age of diagnosis. Additionally, among patients suspected to have a familial cancer syndrome, one-third harbored a germline P/LP variant. Further study of germline variants in patients with familial bladder cancer including somatic testing for loss of heterozygosity may provide insights regarding disease pathogenesis and inform therapy.
- Published
- 2022
179. Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma
- Author
-
Xiao Wei, Marina D Kaymakcalan, Toni K Choueiri, Daniel Y C Heng, Wanling Xie, Sarah Abou Alaiwi, Amin H Nassar, Shaan Dudani, Dylan Martini, Ziad Bakouny, John A Steinharter, Pier Vitale Nuzzo, Ronan Flippot, Nieves Martinez-Chanza, Bradley A McGregor, Mehmet A Bilen, and Lauren C Harshman
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Background Immune checkpoint inhibitors (ICI) induce a range of immune-related adverse events (irAEs) with various degrees of severity. While clinical experience with ICI retreatment following clinically significant irAEs is growing, the safety and efficacy are not yet well characterized.Methods This multicenter retrospective study identified patients with metastatic renal cell carcinoma treated with ICI who had >1 week therapy interruption for irAEs. Patients were classified into retreatment and discontinuation cohorts based on whether or not they resumed an ICI. Toxicity and clinical outcomes were assessed descriptively.Results Of 499 patients treated with ICIs, 80 developed irAEs warranting treatment interruption; 36 (45%) of whom were restarted on an ICI and 44 (55%) who permanently discontinued. Median time to initial irAE was similar between the retreatment and discontinuation cohorts (2.8 vs 2.7 months, p=0.59). The type and grade of irAEs were balanced across the cohorts; however, fewer retreatment patients required corticosteroids (55.6% vs 84.1%, p=0.007) and hospitalizations (33.3% vs 65.9%, p=0.007) for irAE management compared with discontinuation patients. Median treatment holiday before reinitiation was 0.9 months (0.2–31.6). After retreatment, 50% (n=18/36) experienced subsequent irAEs (12 new, 6 recurrent) with 7 (19%) grade 3 events and 13 drug interruptions. Median time to irAE recurrence after retreatment was 2.8 months (range: 0.3–13.8). Retreatment resulted in 6 (23.1%) additional responses in 26 patients whose disease had not previously responded. From first ICI initiation, median time to next therapy was 14.2 months (95% CI 8.2 to 18.9) and 9.0 months (5.3 to 25.8), and 2-year overall survival was 76% (95%CI 55% to 88%) and 66% (48% to 79%) in the retreatment and discontinuation groups, respectively.Conclusions Despite a considerable rate of irAE recurrence with retreatment after a prior clinically significant irAE, most irAEs were low grade and controllable. Prospective studies are warranted to confirm that retreatment enhances survival outcomes that justify the safety risks.
- Published
- 2020
- Full Text
- View/download PDF
180. Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study
- Author
-
Elaine Lam, Marina D Kaymakcalan, Wanling Xie, Sarah Abou Alaiwi, Amin H Nassar, Pier Vitale Nuzzo, Nieves Martinez Chanza, Majd Issa, Hannah Dzimitrowicz, Abhishek Tripathi, Benoit Beuselinck, Yousef Zakharia, Rana Mckay, Sumit Shah, Amir Mortazavi, Michael R. Harrison, Spyridon Sideris, Anis Hamid, Toni K Choueiri, and Lauren C Harshman
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Background There is limited experience regarding the safety and efficacy of checkpoint inhibitors (CPI) in patients with autoimmune disorders (AD) and advanced urological cancers as they are generally excluded from clinical trials due to risk of exacerbations.Methods This multicenter retrospective cohort analysis of patients with advanced renal cell cancer (RCC) and urothelial cancer (UC) with pre-existing AD treated with CPI catalogued the incidence of AD exacerbations, new immune-related adverse events (irAEs) and clinical outcomes. Competing risk models estimated cumulative incidences of exacerbations and new irAEs at 3 and 6 months.Results Of 106 patients with AD (58 RCC, 48 UC) from 10 centers, 35 (33%) had grade 1/2 clinically active AD of whom 10 (9%) required corticosteroids or immunomodulators at baseline. Exacerbations of pre-existing AD occurred in 38 (36%) patients with 17 (45%) requiring corticosteroids and 6 (16%) discontinuing CPI. New onset irAEs occurred in 40 (38%) patients with 22 (55%) requiring corticosteroids and 8 (20%) discontinuing CPI. Grade 3/4 events occurred in 6 (16%) of exacerbations and 13 (33%) of new irAEs. No treatment-related deaths occurred. Median follow-up was 15 months. For RCC, objective response rate (ORR) was 31% (95% CI 20% to 45%), median time to treatment failure (TTF) was 7 months (95% CI 4 to 10) and 12-month overall survival (OS) was 78% (95% CI 63% to 87%). For UC, ORR was 40% (95% CI 26% to 55%), median TTF was 5.0 months (95% CI 2.3 to 9.0) and 12-month OS was 63% (95% CI 47% to 76%).Conclusions Patients with RCC and UC with well-controlled AD can benefit from CPI with manageable toxicities that are consistent with what is expected of a non-AD population. Prospective study is warranted to comprehensively evaluate the benefits and safety of CPI in patients with AD.
- Published
- 2020
- Full Text
- View/download PDF
181. Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors
- Author
-
Guru Sonpavde, Sarah Abou Alaiwi, Amin H Nassar, Pier Vitale Nuzzo, Ronan Flippot, Bradley A McGregor, Lauren C Harshman, Gregory R Pond, Catherine Curran, Kerry L Kilbridge, Xiao X Wei, and Toni Choueiri
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Background Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events (irAEs). Although the incidence and prevalence of irAEs have been well characterized in the literature, less is known about the cumulative incidence rate of irAEs. We studied the cumulative incidence of irAEs, defined as the probability of irAE occurrence over time and the risk factors for irAE development in metastatic urothelial carcinoma (mUC) and renal cell carcinoma (mRCC) patients treated with ICIs.Methods We identified a cohort of patients who received ICIs for mUC and mRCC. irAEs were classified using Common Terminology Criteria for Adverse Event (CTCAE) V.5.0 guidelines. The monthly incidence of irAEs over time was reported after landmark duration of therapy. Cumulative incidence of irAEs was calculated to evaluate the time to the first occurrence of an irAE accounting for the competing risk of death. Prognostic factors for irAE were assessed using the Fine and Gray method.Results A total of 470 patients were treated with ICIs between July 2013 and October 2018 (mUC: 199 (42.3%); mRCC: 271 (57.7%)). 341 (72.6%) patients received monotherapy, 86 (18.3%) received ICIs in combination with targeted therapies, and 43 (9.2%) received dual ICI therapy. Overall, 186 patients (39.5%) experienced an irAE at any time point. Common irAEs included hypothyroidism (n=42, 22.6%), rush and pruritus (n=36, 19.4%), diarrhea/colitis (n=35, 18.8%), transaminitis (n=32, 17.2%), and pneumonitis (n=14, 7.5%). Monthly incidence rates decreased over time; however, 17 of 109 (15.6%, 95% CI: 9.4% to 23.8%) experienced their first irAE at least 1 year after treatment initiation. No differences in cumulative incidence were observed based on cancer type, agent, or irAE grade. On multivariable analysis, combined ICI therapy with another ICI or with targeted therapy (p
- Published
- 2020
- Full Text
- View/download PDF
182. Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review
- Author
-
Muhammad Umer Ahmed, Muhammad Hanif, Mukarram Jamat Ali, Muhammad Adnan Haider, Danish Kherani, Gul Muhammad Memon, Amin H. Karim, and Abdul Sattar
- Subjects
SARS-CoV-2 ,COVID-19 ,neurotropism ,neurological manifestations ,encephalitis ,encephalomyelitis ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been associated with many neurological symptoms but there is a little evidence-based published material on the neurological manifestations of COVID-19. The purpose of this article is to review the spectrum of the various neurological manifestations and underlying associated pathophysiology in COVID-19 patients.Method: We conducted a review of the various case reports and retrospective clinical studies published on the neurological manifestations, associated literature, and related pathophysiology of COVID-19 using PUBMED and subsequent proceedings. A total of 118 articles were thoroughly reviewed in order to highlight the plausible spectrum of neurological manifestations of COVID 19. Every article was either based on descriptive analysis, clinical scenarios, correspondence, and editorials emphasizing the neurological manifestations either directly or indirectly. We then tried to highlight the significant plausible manifestations and complications that could be related to the pandemic. With little known about the dynamics and the presentation spectrum of the virus apart from the respiratory symptoms, this area needs further consideration.Conclusion: The neurological manifestations associated with COVID-19 such as Encephalitis, Meningitis, acute cerebrovascular disease, and Guillain Barré Syndrome (GBS) are of great concern. But in the presence of life-threatening abnormal vitals in severely ill COVID-19 patients, these are not usually underscored. There is a need to diagnose these manifestations at the earliest to limit long term sequelae. Much research is needed to explore the role of SARS-CoV-2 in causing these neurological manifestations by isolating it either from cerebrospinal fluid or brain tissues of the deceased on autopsy. We also recommend exploring the risk factors that lead to the development of these neurological manifestations.
- Published
- 2020
- Full Text
- View/download PDF
183. The emerging landscape of germline variants in urothelial carcinoma: Implications for genetic testing
- Author
-
Panagiotis J. Vlachostergios, M.D., Ph.D., Bishoy M. Faltas, M.D., Maria I. Carlo, M.D., Amin H. Nassar, M.D., Sarah Abou Alaiwi, M.D., and Guru Sonpavde, M.D.
- Subjects
Bladder cancer ,Genetic testing ,Germline variants ,Urothelial carcinoma ,Lynch syndrome ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Urothelial carcinoma (UC) of the bladder and upper tract (ureter, renal pelvis) is one of the most frequently occurring malignancies. While the majority of UC are chemically induced by smoking, accumulating evidence from genetic studies have demonstrated a small, but consistent impact of heritable gene variants and family history of UC on the development of the disease. Beyond the established association between upper tract UC and germline mismatch DNA repair defects as a defining feature of Lynch syndrome, newer investigations focusing on moderate- and high-risk cancer-related gene variants in DNA damage repair and other signaling pathways are expanding our knowledge on the heritable genetic basis of UC, opening new avenues in the breadth of genetic testing and in clinical counseling of these patients. Overcoming existing challenges in the interpretation of uncertain findings and family cascade testing may help expand our testing approach and guidelines. Following the paradigm of other tumor types, such as breast and ovarian cancers, germline genetic testing, particularly when combined with somatic testing, has the potential to directly benefit affected UC patients and their families in the future through therapeutic targeting (i.e. with poly(ADP-ribose)) polymerase inhibitors, immune checkpoint inhibitors) and genetically informed screening/surveillance, respectively.
- Published
- 2020
- Full Text
- View/download PDF
184. Editorial: Methods in genitourinary oncology
- Author
-
Jang, Albert, primary, Sella, Avishay, additional, Nassar, Amin H., additional, and Koshkin, Vadim S., additional
- Published
- 2023
- Full Text
- View/download PDF
185. Epigenomic profiling nominates master transcription factors (TFs) driving sarcomatoid differentiation (SD) of renal cell carcinoma (RCC)
- Author
-
El Zarif, Talal, primary, Semaan, Karl, additional, Eid, Marc, additional, Fortunato, Brad, additional, Nassar, Amin H, additional, Abou Alaiwi, Sarah, additional, Bakouny, Ziad, additional, Shah, Valisha, additional, Maria Saliby, Renee, additional, Seo, Ji-Heui, additional, Labaki, Chris, additional, Saad, Eddy, additional, Garinet, Simon, additional, Matar, Sayed, additional, Ahmar, Nourhan, additional, Nabil Laimon, Yasmin, additional, Mary Lee, Gwo-Shu, additional, Pomerantz, Mark, additional, E Berchuck, Jacob, additional, Viswanathan, Srinivas R, additional, Signoretti, Sabina, additional, Van Allen, Eliezer M, additional, Braun, David, additional, K Choueiri, Toni, additional, L Freedman, Matt, additional, and Baca, Sylvan S, additional
- Published
- 2023
- Full Text
- View/download PDF
186. Face mask recognition during KYC generation from a live photo detection methodology
- Author
-
Barua, Debalina, primary, Ahsan, Mumtahina, additional, Khandaker, Moumita, additional, Amin, H M Zahidul, additional, Mehedi, Md Humaion Kabir, additional, and Rasel, Annajiat Alim, additional
- Published
- 2023
- Full Text
- View/download PDF
187. Model of Narcotics Criminal Investigation Authority between BNN and Police of the Republic of Indonesia Based on Justice Value
- Author
-
Mulyadi, Gusti, primary, Mashdurohatun, Anis, additional, Soponyono, Eko, additional, and Amin, H. M. Ercham, additional
- Published
- 2023
- Full Text
- View/download PDF
188. Abstract A029: Epigenomic profiling nominates master transcription factors (TFs) driving sarcomatoid differentiation of renal cell carcinoma (RCC)
- Author
-
Semaan, Karl, primary, Zarif, Talal El, additional, Eid, Marc, additional, Shah, Valisha, additional, Fortunato, Brad, additional, Saliby, Renee Maria, additional, Nassar, Amin H., additional, Alaiwi, Sarah Abou, additional, Seo, Ji-Heui, additional, Labaki, Chris, additional, Bakouny, Ziad, additional, Matar, Sayed, additional, Ahmar, Nourhan El, additional, Laimon, Yasmin Nabil, additional, Lee, Gwo-Shu Mary, additional, Pomerantz, Mark, additional, Berchuck, Jacob, additional, Signoretti, Sabina, additional, Van Allen, Eliezer, additional, Choueiri, Toni, additional, Braun, David, additional, Freedman, Matthew, additional, and Baca, Sylvan, additional
- Published
- 2023
- Full Text
- View/download PDF
189. Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors
- Author
-
El Zarif, Talal, primary, Nassar, Amin H, additional, Pond, Gregory R, additional, Zhuang, Tony Zibo, additional, Master, Viraj, additional, Nazha, Bassel, additional, Niglio, Scot, additional, Simon, Nicholas, additional, Hahn, Andrew W, additional, Pettaway, Curtis A, additional, Tu, Shi-Ming, additional, Abdel-Wahab, Noha, additional, Velev, Maud, additional, Flippot, Ronan, additional, Buti, Sebastiano, additional, Maruzzo, Marco, additional, Mittra, Arjun, additional, Gheeya, Jinesh, additional, Yang, Yuanquan, additional, Rodriguez, Pablo Alvarez, additional, Castellano, Daniel, additional, de Velasco, Guillermo, additional, Roviello, Giandomenico, additional, Antonuzzo, Lorenzo, additional, McKay, Rana R, additional, Vincenzi, Bruno, additional, Cortellini, Alessio, additional, Hui, Gavin, additional, Drakaki, Alexandra, additional, Glover, Michael, additional, Khaki, Ali Raza, additional, El-Am, Edward, additional, Adra, Nabil, additional, Mouhieddine, Tarek H, additional, Patel, Vaibhav, additional, Piedra, Aida, additional, Gernone, Angela, additional, Davis, Nancy B, additional, Matthews, Harrison, additional, Harrison, Michael R, additional, Kanesvaran, Ravindran, additional, Giudice, Giulia Claire, additional, Barata, Pedro, additional, Farolfi, Alberto, additional, Lee, Jae Lyun, additional, Milowsky, Matthew I, additional, Stahlfeld, Charlotte, additional, Appleman, Leonard, additional, Kim, Joseph W, additional, Freeman, Dory, additional, Choueiri, Toni K, additional, Spiess, Philippe E, additional, Necchi, Andrea, additional, Apolo, Andrea B, additional, and Sonpavde, Guru P, additional
- Published
- 2023
- Full Text
- View/download PDF
190. B0.1In0.9P Quantum Dot Semiconductor Optical Amplifiers
- Author
-
Almosawi, Buraq T. Sh., primary, Al-Hashimi, Mohammed K., additional, Al-Nashy, Baqer Obaid, additional, and Al-Khursan, Amin H., additional
- Published
- 2023
- Full Text
- View/download PDF
191. TERT Promoter Mutations Frequency Across Race, Sex, and Cancer Type
- Author
-
El Zarif, Talal, primary, Machaalani, Marc, additional, Nawfal, Rashad, additional, Nassar, Amin H, additional, Xie, Wanling, additional, Choueiri, Toni K, additional, and Pomerantz, Mark, additional
- Published
- 2023
- Full Text
- View/download PDF
192. A near-optimum multi-objective optimization approach for structural design
- Author
-
Okasha, Nader M., primary, Alzo'ubi, Abdel Kareem, additional, Mughieda, Omer, additional, Kewalramani, Manish, additional, and Almasri, Amin H., additional
- Published
- 2023
- Full Text
- View/download PDF
193. Perioperative Complications in Patients With Sleep Apnea Undergoing Total Joint Arthroplasty
- Author
-
Naqvi, Syed Y., Rabiei, Amin H., Maltenfort, Mitchell G., Restrepo, Camilo, Viscusi, Eugene R., Parvizi, Javad, and Rasouli, Mohammad R.
- Published
- 2017
- Full Text
- View/download PDF
194. Magnetization reversal of exchange-coupled and exchange-decoupled Nd-Fe-B magnets observed by magneto-optical Kerr effect microscopy
- Author
-
Soderžnik, M., Sepehri-Amin, H., Sasaki, T.T., Ohkubo, T., Takada, Y., Sato, T., Kaneko, Y., Kato, A., Schrefl, T., and Hono, K.
- Published
- 2017
- Full Text
- View/download PDF
195. Equivocal significance of post-ictal generalized EEG suppression as a marker of SUDEP risk
- Author
-
Kang, Joon Y., Rabiei, Amin H., Myint, Leslie, and Nei, Maromi
- Published
- 2017
- Full Text
- View/download PDF
196. Correlation of microchemistry of cell boundary phase and interface structure to the coercivity of Sm(Co0.784Fe0.100Cu0.088Zr0.028)7.19 sintered magnets
- Author
-
Sepehri-Amin, H., Thielsch, J., Fischbacher, J., Ohkubo, T., Schrefl, T., Gutfleisch, O., and Hono, K.
- Published
- 2017
- Full Text
- View/download PDF
197. Microstructure and magnetic properties of grain boundary modified recycled Nd-Fe-B sintered magnets
- Author
-
Sepehri-Amin, H., Ohkubo, T., Zakotnik, M., Prosperi, D., Afiuny, P., Tudor, C.O., and Hono, K.
- Published
- 2017
- Full Text
- View/download PDF
198. Coercivities of hot-deformed magnets processed from amorphous and nanocrystalline precursors
- Author
-
Tang, Xin, Sepehri-Amin, H., Ohkubo, T., Hioki, K., Hattori, A., and Hono, K.
- Published
- 2017
- Full Text
- View/download PDF
199. Giant gain from spontaneously generated coherence in Y-type double quantum dot structure
- Author
-
Al-Nashy, B., Razzaghi, Sonia, Al-Musawi, Muwaffaq Abdullah, Rasooli Saghai, H., and Al-Khursan, Amin H.
- Published
- 2017
- Full Text
- View/download PDF
200. Four-wave mixing in quantum dot SOAs: Theory of carrier heating
- Author
-
Flayyih, Ahmed H., Al-Shatravi, Ali Gehad, and Al-Khursan, Amin H.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.